Author: Ören Hale Şahin Bariş İrken Gülersu Ateş Halil Duman Murat Yılmaz Şebnem Türker MD Atabay Berna Yaprak Işin
Publisher: Informa Healthcare
ISSN: 1521-0669
Source: Pediatric Hematology and Oncology, Vol.20, Iss.3, 2003-04, pp. : 237-243
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Bozdogan Gunseli Erdem Ela Demirel Gulderen Yanikkaya Yildirmak Yildiz
Pediatric Hematology and Oncology, Vol. 27, Iss. 7, 2010-09 ,pp. :
SENSORY NEURAL HEARING LOSS IN β-THALASSEMIA MAJOR PATIENTS TREATED WITH DEFEROXAMINE
By Shamsian Bibi Shahin Aminasnafi Ali Moghadassian Habiballah Gachkar Latif Arzanian M. Taghi Alavi Samin Esfehani Hossein Garallahi Farnoush Amini Reyhaneh
Pediatric Hematology and Oncology, Vol. 25, Iss. 6, 2008-08 ,pp. :
MARKERS OF BONE METABOLISM IN EUGONADAL FEMALE PATIENTS WITH β-THALASSEMIA MAJOR
By Angelopoulos Nicholas G. Goula Anastasia Katounda Eugenia Rombopoulos Grigorios Kaltzidou Victoria Kaltsas Dimitrios Konstandelou Evangellia Tolis George
Pediatric Hematology and Oncology, Vol. 24, Iss. 7, 2007-09 ,pp. :